|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:USP14-DDB2 (FusionGDB2 ID:96548) |
Fusion Gene Summary for USP14-DDB2 |
Fusion gene summary |
Fusion gene information | Fusion gene name: USP14-DDB2 | Fusion gene ID: 96548 | Hgene | Tgene | Gene symbol | USP14 | DDB2 | Gene ID | 9097 | 1643 |
Gene name | ubiquitin specific peptidase 14 | damage specific DNA binding protein 2 | |
Synonyms | TGT | DDBB|UV-DDB2|XPE | |
Cytomap | 18p11.32 | 11p11.2 | |
Type of gene | protein-coding | protein-coding | |
Description | ubiquitin carboxyl-terminal hydrolase 14deubiquitinating enzyme 14tRNA-guanine transglycosylase, 60-kD subunitubiquitin specific peptidase 14 (tRNA-guanine transglycosylase)ubiquitin specific protease 14 (tRNA-guanine transglycosylase)ubiquitin thioe | DNA damage-binding protein 2DDB p48 subunitUV-DDB 2UV-damaged DNA-binding protein 2damage-specific DNA binding protein 2, 48kDaxeroderma pigmentosum group E protein | |
Modification date | 20200329 | 20200327 | |
UniProtAcc | . | Q92466 | |
Ensembl transtripts involved in fusion gene | ENST00000582707, ENST00000400266, ENST00000383589, ENST00000261601, | ENST00000378600, ENST00000378603, ENST00000256996, ENST00000378601, | |
Fusion gene scores | * DoF score | 9 X 7 X 5=315 | 12 X 6 X 7=504 |
# samples | 9 | 11 | |
** MAII score | log2(9/315*10)=-1.8073549220576 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(11/504*10)=-2.19592020997526 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: USP14 [Title/Abstract] AND DDB2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | USP14(166819)-DDB2(47259387), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | USP14 | GO:0016579 | protein deubiquitination | 23958854 |
Tgene | DDB2 | GO:0000209 | protein polyubiquitination | 12732143 |
Tgene | DDB2 | GO:0009411 | response to UV | 12732143 |
Tgene | DDB2 | GO:0035518 | histone H2A monoubiquitination | 22334663 |
Tgene | DDB2 | GO:0051865 | protein autoubiquitination | 12732143 |
Tgene | DDB2 | GO:0070914 | UV-damage excision repair | 22334663 |
Fusion gene breakpoints across USP14 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across DDB2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | ESCA | TCGA-VR-AA4D | USP14 | chr18 | 166819 | + | DDB2 | chr11 | 47259387 | + |
ChimerDB4 | ESCA | TCGA-VR-AA4D | USP14 | chr18 | 166819 | + | DDB2 | chr11 | 47259387 | + |
Top |
Fusion Gene ORF analysis for USP14-DDB2 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000582707 | ENST00000378600 | USP14 | chr18 | 166819 | + | DDB2 | chr11 | 47259387 | + |
In-frame | ENST00000582707 | ENST00000378603 | USP14 | chr18 | 166819 | + | DDB2 | chr11 | 47259387 | + |
In-frame | ENST00000582707 | ENST00000256996 | USP14 | chr18 | 166819 | + | DDB2 | chr11 | 47259387 | + |
5CDS-3UTR | ENST00000582707 | ENST00000378601 | USP14 | chr18 | 166819 | + | DDB2 | chr11 | 47259387 | + |
intron-3CDS | ENST00000400266 | ENST00000378600 | USP14 | chr18 | 166819 | + | DDB2 | chr11 | 47259387 | + |
intron-3CDS | ENST00000400266 | ENST00000378603 | USP14 | chr18 | 166819 | + | DDB2 | chr11 | 47259387 | + |
intron-3CDS | ENST00000400266 | ENST00000256996 | USP14 | chr18 | 166819 | + | DDB2 | chr11 | 47259387 | + |
intron-3UTR | ENST00000400266 | ENST00000378601 | USP14 | chr18 | 166819 | + | DDB2 | chr11 | 47259387 | + |
intron-3CDS | ENST00000383589 | ENST00000378600 | USP14 | chr18 | 166819 | + | DDB2 | chr11 | 47259387 | + |
intron-3CDS | ENST00000383589 | ENST00000378603 | USP14 | chr18 | 166819 | + | DDB2 | chr11 | 47259387 | + |
intron-3CDS | ENST00000383589 | ENST00000256996 | USP14 | chr18 | 166819 | + | DDB2 | chr11 | 47259387 | + |
intron-3UTR | ENST00000383589 | ENST00000378601 | USP14 | chr18 | 166819 | + | DDB2 | chr11 | 47259387 | + |
In-frame | ENST00000261601 | ENST00000378600 | USP14 | chr18 | 166819 | + | DDB2 | chr11 | 47259387 | + |
In-frame | ENST00000261601 | ENST00000378603 | USP14 | chr18 | 166819 | + | DDB2 | chr11 | 47259387 | + |
In-frame | ENST00000261601 | ENST00000256996 | USP14 | chr18 | 166819 | + | DDB2 | chr11 | 47259387 | + |
5CDS-3UTR | ENST00000261601 | ENST00000378601 | USP14 | chr18 | 166819 | + | DDB2 | chr11 | 47259387 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000582707 | USP14 | chr18 | 166819 | + | ENST00000378600 | DDB2 | chr11 | 47259387 | + | 1139 | 511 | 109 | 771 | 220 |
ENST00000582707 | USP14 | chr18 | 166819 | + | ENST00000378603 | DDB2 | chr11 | 47259387 | + | 1139 | 511 | 109 | 771 | 220 |
ENST00000582707 | USP14 | chr18 | 166819 | + | ENST00000256996 | DDB2 | chr11 | 47259387 | + | 1139 | 511 | 109 | 771 | 220 |
ENST00000261601 | USP14 | chr18 | 166819 | + | ENST00000378600 | DDB2 | chr11 | 47259387 | + | 914 | 286 | 13 | 546 | 177 |
ENST00000261601 | USP14 | chr18 | 166819 | + | ENST00000378603 | DDB2 | chr11 | 47259387 | + | 914 | 286 | 13 | 546 | 177 |
ENST00000261601 | USP14 | chr18 | 166819 | + | ENST00000256996 | DDB2 | chr11 | 47259387 | + | 914 | 286 | 13 | 546 | 177 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000582707 | ENST00000378600 | USP14 | chr18 | 166819 | + | DDB2 | chr11 | 47259387 | + | 0.002943087 | 0.99705696 |
ENST00000582707 | ENST00000378603 | USP14 | chr18 | 166819 | + | DDB2 | chr11 | 47259387 | + | 0.002943087 | 0.99705696 |
ENST00000582707 | ENST00000256996 | USP14 | chr18 | 166819 | + | DDB2 | chr11 | 47259387 | + | 0.002943087 | 0.99705696 |
ENST00000261601 | ENST00000378600 | USP14 | chr18 | 166819 | + | DDB2 | chr11 | 47259387 | + | 0.005065336 | 0.99493474 |
ENST00000261601 | ENST00000378603 | USP14 | chr18 | 166819 | + | DDB2 | chr11 | 47259387 | + | 0.005065336 | 0.99493474 |
ENST00000261601 | ENST00000256996 | USP14 | chr18 | 166819 | + | DDB2 | chr11 | 47259387 | + | 0.005065336 | 0.99493474 |
Top |
Fusion Genomic Features for USP14-DDB2 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
USP14 | chr18 | 166819 | + | DDB2 | chr11 | 47259387 | + | 1.75E-05 | 0.9999825 |
USP14 | chr18 | 166819 | + | DDB2 | chr11 | 47259387 | + | 1.75E-05 | 0.9999825 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for USP14-DDB2 |
Go to FGviewer for the breakpoints of chr18:166819-chr11:47259387 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | DDB2 |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Protein, which is both involved in DNA repair and protein ubiquitination, as part of the UV-DDB complex and DCX (DDB1-CUL4-X-box) complexes, respectively (PubMed:10882109, PubMed:11278856, PubMed:11705987, PubMed:9892649, PubMed:12732143, PubMed:15882621, PubMed:16473935, PubMed:18593899). Core component of the UV-DDB complex (UV-damaged DNA-binding protein complex), a complex that recognizes UV-induced DNA damage and recruit proteins of the nucleotide excision repair pathway (the NER pathway) to initiate DNA repair (PubMed:10882109, PubMed:11278856, PubMed:11705987, PubMed:16260596, PubMed:12944386, PubMed:14751237). The UV-DDB complex preferentially binds to cyclobutane pyrimidine dimers (CPD), 6-4 photoproducts (6-4 PP), apurinic sites and short mismatches (PubMed:10882109, PubMed:11278856, PubMed:11705987, PubMed:16260596, PubMed:12944386). Also functions as the substrate recognition module for the DCX (DDB2-CUL4-X-box) E3 ubiquitin-protein ligase complex DDB2-CUL4-ROC1 (also known as CUL4-DDB-ROC1 and CUL4-DDB-RBX1) (PubMed:12732143, PubMed:15882621, PubMed:16473935, PubMed:18593899, PubMed:26572825). The DDB2-CUL4-ROC1 complex may ubiquitinate histone H2A, histone H3 and histone H4 at sites of UV-induced DNA damage (PubMed:16678110, PubMed:16473935). The ubiquitination of histones may facilitate their removal from the nucleosome and promote subsequent DNA repair (PubMed:16678110, PubMed:16473935). The DDB2-CUL4-ROC1 complex also ubiquitinates XPC, which may enhance DNA-binding by XPC and promote NER (PubMed:15882621). The DDB2-CUL4-ROC1 complex also ubiquitinates KAT7/HBO1 in response to DNA damage, leading to its degradation: recognizes KAT7/HBO1 following phosphorylation by ATR (PubMed:26572825). {ECO:0000269|PubMed:10882109, ECO:0000269|PubMed:11278856, ECO:0000269|PubMed:11705987, ECO:0000269|PubMed:12732143, ECO:0000269|PubMed:12944386, ECO:0000269|PubMed:14751237, ECO:0000269|PubMed:15882621, ECO:0000269|PubMed:16260596, ECO:0000269|PubMed:16473935, ECO:0000269|PubMed:16678110, ECO:0000269|PubMed:18593899, ECO:0000269|PubMed:26572825, ECO:0000269|PubMed:9892649}.; FUNCTION: [Isoform D1]: Inhibits UV-damaged DNA repair. {ECO:0000269|PubMed:14751237}.; FUNCTION: [Isoform D2]: Inhibits UV-damaged DNA repair. {ECO:0000269|PubMed:14751237}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000378600 | 2 | 6 | 256_274 | 152.0 | 239.0 | Motif | Note=DWD box | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000378600 | 2 | 6 | 334_336 | 152.0 | 239.0 | Region | Note=Photolesion recognition | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000378601 | 5 | 9 | 334_336 | 281.6666666666667 | 237.33333333333334 | Region | Note=Photolesion recognition | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000378603 | 5 | 9 | 334_336 | 277.0 | 364.0 | Region | Note=Photolesion recognition | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000256996 | 6 | 10 | 343_386 | 341.0 | 428.0 | Repeat | WD 6 | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000256996 | 6 | 10 | 396_420 | 341.0 | 428.0 | Repeat | WD 7 | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000378600 | 2 | 6 | 159_194 | 152.0 | 239.0 | Repeat | WD 2 | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000378600 | 2 | 6 | 203_238 | 152.0 | 239.0 | Repeat | WD 3 | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000378600 | 2 | 6 | 244_287 | 152.0 | 239.0 | Repeat | WD 4 | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000378600 | 2 | 6 | 290_329 | 152.0 | 239.0 | Repeat | WD 5 | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000378600 | 2 | 6 | 343_386 | 152.0 | 239.0 | Repeat | WD 6 | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000378600 | 2 | 6 | 396_420 | 152.0 | 239.0 | Repeat | WD 7 | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000378601 | 5 | 9 | 290_329 | 281.6666666666667 | 237.33333333333334 | Repeat | WD 5 | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000378601 | 5 | 9 | 343_386 | 281.6666666666667 | 237.33333333333334 | Repeat | WD 6 | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000378601 | 5 | 9 | 396_420 | 281.6666666666667 | 237.33333333333334 | Repeat | WD 7 | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000378603 | 5 | 9 | 290_329 | 277.0 | 364.0 | Repeat | WD 5 | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000378603 | 5 | 9 | 343_386 | 277.0 | 364.0 | Repeat | WD 6 | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000378603 | 5 | 9 | 396_420 | 277.0 | 364.0 | Repeat | WD 7 |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | USP14 | chr18:166819 | chr11:47259387 | ENST00000261601 | + | 3 | 16 | 105_483 | 65.0 | 495.0 | Domain | Note=USP |
Hgene | USP14 | chr18:166819 | chr11:47259387 | ENST00000261601 | + | 3 | 16 | 4_80 | 65.0 | 495.0 | Domain | Ubiquitin-like |
Hgene | USP14 | chr18:166819 | chr11:47259387 | ENST00000582707 | + | 3 | 15 | 105_483 | 65.0 | 460.0 | Domain | Note=USP |
Hgene | USP14 | chr18:166819 | chr11:47259387 | ENST00000582707 | + | 3 | 15 | 4_80 | 65.0 | 460.0 | Domain | Ubiquitin-like |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000256996 | 6 | 10 | 256_274 | 341.0 | 428.0 | Motif | Note=DWD box | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000378601 | 5 | 9 | 256_274 | 281.6666666666667 | 237.33333333333334 | Motif | Note=DWD box | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000378603 | 5 | 9 | 256_274 | 277.0 | 364.0 | Motif | Note=DWD box | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000256996 | 6 | 10 | 334_336 | 341.0 | 428.0 | Region | Note=Photolesion recognition | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000256996 | 6 | 10 | 116_151 | 341.0 | 428.0 | Repeat | WD 1 | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000256996 | 6 | 10 | 159_194 | 341.0 | 428.0 | Repeat | WD 2 | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000256996 | 6 | 10 | 203_238 | 341.0 | 428.0 | Repeat | WD 3 | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000256996 | 6 | 10 | 244_287 | 341.0 | 428.0 | Repeat | WD 4 | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000256996 | 6 | 10 | 290_329 | 341.0 | 428.0 | Repeat | WD 5 | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000378600 | 2 | 6 | 116_151 | 152.0 | 239.0 | Repeat | WD 1 | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000378601 | 5 | 9 | 116_151 | 281.6666666666667 | 237.33333333333334 | Repeat | WD 1 | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000378601 | 5 | 9 | 159_194 | 281.6666666666667 | 237.33333333333334 | Repeat | WD 2 | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000378601 | 5 | 9 | 203_238 | 281.6666666666667 | 237.33333333333334 | Repeat | WD 3 | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000378601 | 5 | 9 | 244_287 | 281.6666666666667 | 237.33333333333334 | Repeat | WD 4 | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000378603 | 5 | 9 | 116_151 | 277.0 | 364.0 | Repeat | WD 1 | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000378603 | 5 | 9 | 159_194 | 277.0 | 364.0 | Repeat | WD 2 | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000378603 | 5 | 9 | 203_238 | 277.0 | 364.0 | Repeat | WD 3 | |
Tgene | DDB2 | chr18:166819 | chr11:47259387 | ENST00000378603 | 5 | 9 | 244_287 | 277.0 | 364.0 | Repeat | WD 4 |
Top |
Fusion Gene Sequence for USP14-DDB2 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000582707_ENST00000378600_TCGA-VR-AA4D_USP14_chr18_166819_+_DDB2_chr11_47259387_length(transcript)=1139nt_BP=511nt CCCTCACTTGCTCCCTCCTTCCTTCCCGCCACCCCTCCACCGCCTTCCCCCTCCTCCCTCCTCTCGCCACCTCTAGGCCCCGCCCCGGTC CTGCCGCCCAGTCTCCTCGCTGCAGTCGCTCCGGAGCTGCACGGGTGTTTTGCGTGTTGCTGCGTCATCGCCAGTGGCCGGTTTGAATGA GACTCGTCGCACCGAAGCCGCCGCCACCACCGCGCCTCCGCCTCGGCCGCCGCCGCAGCTGCTCCTGGTCCCCGTCCCTTTGCCGCCCTC GTCAGGCCCAGCTCTCCTGCGCCGCCGCCTCCCGCCGCGCCCCGCCATGCCGCTCTACTCCGTTACTGTAAAATGGGGAAAGGAGAAATT TGAAGGTGTAGAATTGAATACAGATGAACCTCCAATGGTATTCAAGGCTCAGCTGTTTGCGTTGACTGGAGTCCAGCCTGCCAGACAGAA AGTTATGGTGAAAGGAGGAACGCTAAAGGATGATGATTGGGGAAACATCAAAATAAAAAATGCAGCCTGGCATCCTCGCTACAACCTCAT TGTTGTGGGCCGATACCCAGATCCTAATTTCAAAAGTTGTACCCCTTATGAATTGAGGACGATCGACGTGTTCGATGGAAACTCAGGGAA GATGATGTGTCAGCTCTATGACCCAGAATCTTCTGGCATCAGTTCGCTTAATGAATTCAATCCCATGGGGGACACGCTGGCCTCTGCAAT GGGTTACCACATTCTCATCTGGAGCCAGGAGGAAGCCAGGACACGGAAGTGAGAGACACTAAAGAAGGTGTGGGCCAGACAAGGCCTTGG AGCCCACACATGGGATCAAGTCCTGCAAGCAGAGGTGGCGATTTGTTAAAGGGCCAAAAGTATCCAAGGTTAGGGTTGGAGCAGGGGTGC TGGGACCTGGGGCACTGTGGGACTGGGACACTTTTATGTTAATGCTCTGGACTTGCCTCCAGAGACTGCTCCAGAGTTGGTGACACAGCT GTCCCAAGGGCCCCTCTGTATCTAGCCTGGAACCAAGGTTATCTTGGAACTAAATGACTTTTCTCCTCTCAGTGGGTGGTAGCAGAGGGA >In-frame_ENST00000582707_ENST00000378600_TCGA-VR-AA4D_USP14_chr18_166819_+_DDB2_chr11_47259387_length(amino acids)=220AA_start in transcript=109_stop in transcript=771 MQSLRSCTGVLRVAASSPVAGLNETRRTEAAATTAPPPRPPPQLLLVPVPLPPSSGPALLRRRLPPRPAMPLYSVTVKWGKEKFEGVELN TDEPPMVFKAQLFALTGVQPARQKVMVKGGTLKDDDWGNIKIKNAAWHPRYNLIVVGRYPDPNFKSCTPYELRTIDVFDGNSGKMMCQLY -------------------------------------------------------------- >In-frame_ENST00000582707_ENST00000378603_TCGA-VR-AA4D_USP14_chr18_166819_+_DDB2_chr11_47259387_length(transcript)=1139nt_BP=511nt CCCTCACTTGCTCCCTCCTTCCTTCCCGCCACCCCTCCACCGCCTTCCCCCTCCTCCCTCCTCTCGCCACCTCTAGGCCCCGCCCCGGTC CTGCCGCCCAGTCTCCTCGCTGCAGTCGCTCCGGAGCTGCACGGGTGTTTTGCGTGTTGCTGCGTCATCGCCAGTGGCCGGTTTGAATGA GACTCGTCGCACCGAAGCCGCCGCCACCACCGCGCCTCCGCCTCGGCCGCCGCCGCAGCTGCTCCTGGTCCCCGTCCCTTTGCCGCCCTC GTCAGGCCCAGCTCTCCTGCGCCGCCGCCTCCCGCCGCGCCCCGCCATGCCGCTCTACTCCGTTACTGTAAAATGGGGAAAGGAGAAATT TGAAGGTGTAGAATTGAATACAGATGAACCTCCAATGGTATTCAAGGCTCAGCTGTTTGCGTTGACTGGAGTCCAGCCTGCCAGACAGAA AGTTATGGTGAAAGGAGGAACGCTAAAGGATGATGATTGGGGAAACATCAAAATAAAAAATGCAGCCTGGCATCCTCGCTACAACCTCAT TGTTGTGGGCCGATACCCAGATCCTAATTTCAAAAGTTGTACCCCTTATGAATTGAGGACGATCGACGTGTTCGATGGAAACTCAGGGAA GATGATGTGTCAGCTCTATGACCCAGAATCTTCTGGCATCAGTTCGCTTAATGAATTCAATCCCATGGGGGACACGCTGGCCTCTGCAAT GGGTTACCACATTCTCATCTGGAGCCAGGAGGAAGCCAGGACACGGAAGTGAGAGACACTAAAGAAGGTGTGGGCCAGACAAGGCCTTGG AGCCCACACATGGGATCAAGTCCTGCAAGCAGAGGTGGCGATTTGTTAAAGGGCCAAAAGTATCCAAGGTTAGGGTTGGAGCAGGGGTGC TGGGACCTGGGGCACTGTGGGACTGGGACACTTTTATGTTAATGCTCTGGACTTGCCTCCAGAGACTGCTCCAGAGTTGGTGACACAGCT GTCCCAAGGGCCCCTCTGTATCTAGCCTGGAACCAAGGTTATCTTGGAACTAAATGACTTTTCTCCTCTCAGTGGGTGGTAGCAGAGGGA >In-frame_ENST00000582707_ENST00000378603_TCGA-VR-AA4D_USP14_chr18_166819_+_DDB2_chr11_47259387_length(amino acids)=220AA_start in transcript=109_stop in transcript=771 MQSLRSCTGVLRVAASSPVAGLNETRRTEAAATTAPPPRPPPQLLLVPVPLPPSSGPALLRRRLPPRPAMPLYSVTVKWGKEKFEGVELN TDEPPMVFKAQLFALTGVQPARQKVMVKGGTLKDDDWGNIKIKNAAWHPRYNLIVVGRYPDPNFKSCTPYELRTIDVFDGNSGKMMCQLY -------------------------------------------------------------- >In-frame_ENST00000582707_ENST00000256996_TCGA-VR-AA4D_USP14_chr18_166819_+_DDB2_chr11_47259387_length(transcript)=1139nt_BP=511nt CCCTCACTTGCTCCCTCCTTCCTTCCCGCCACCCCTCCACCGCCTTCCCCCTCCTCCCTCCTCTCGCCACCTCTAGGCCCCGCCCCGGTC CTGCCGCCCAGTCTCCTCGCTGCAGTCGCTCCGGAGCTGCACGGGTGTTTTGCGTGTTGCTGCGTCATCGCCAGTGGCCGGTTTGAATGA GACTCGTCGCACCGAAGCCGCCGCCACCACCGCGCCTCCGCCTCGGCCGCCGCCGCAGCTGCTCCTGGTCCCCGTCCCTTTGCCGCCCTC GTCAGGCCCAGCTCTCCTGCGCCGCCGCCTCCCGCCGCGCCCCGCCATGCCGCTCTACTCCGTTACTGTAAAATGGGGAAAGGAGAAATT TGAAGGTGTAGAATTGAATACAGATGAACCTCCAATGGTATTCAAGGCTCAGCTGTTTGCGTTGACTGGAGTCCAGCCTGCCAGACAGAA AGTTATGGTGAAAGGAGGAACGCTAAAGGATGATGATTGGGGAAACATCAAAATAAAAAATGCAGCCTGGCATCCTCGCTACAACCTCAT TGTTGTGGGCCGATACCCAGATCCTAATTTCAAAAGTTGTACCCCTTATGAATTGAGGACGATCGACGTGTTCGATGGAAACTCAGGGAA GATGATGTGTCAGCTCTATGACCCAGAATCTTCTGGCATCAGTTCGCTTAATGAATTCAATCCCATGGGGGACACGCTGGCCTCTGCAAT GGGTTACCACATTCTCATCTGGAGCCAGGAGGAAGCCAGGACACGGAAGTGAGAGACACTAAAGAAGGTGTGGGCCAGACAAGGCCTTGG AGCCCACACATGGGATCAAGTCCTGCAAGCAGAGGTGGCGATTTGTTAAAGGGCCAAAAGTATCCAAGGTTAGGGTTGGAGCAGGGGTGC TGGGACCTGGGGCACTGTGGGACTGGGACACTTTTATGTTAATGCTCTGGACTTGCCTCCAGAGACTGCTCCAGAGTTGGTGACACAGCT GTCCCAAGGGCCCCTCTGTATCTAGCCTGGAACCAAGGTTATCTTGGAACTAAATGACTTTTCTCCTCTCAGTGGGTGGTAGCAGAGGGA >In-frame_ENST00000582707_ENST00000256996_TCGA-VR-AA4D_USP14_chr18_166819_+_DDB2_chr11_47259387_length(amino acids)=220AA_start in transcript=109_stop in transcript=771 MQSLRSCTGVLRVAASSPVAGLNETRRTEAAATTAPPPRPPPQLLLVPVPLPPSSGPALLRRRLPPRPAMPLYSVTVKWGKEKFEGVELN TDEPPMVFKAQLFALTGVQPARQKVMVKGGTLKDDDWGNIKIKNAAWHPRYNLIVVGRYPDPNFKSCTPYELRTIDVFDGNSGKMMCQLY -------------------------------------------------------------- >In-frame_ENST00000261601_ENST00000378600_TCGA-VR-AA4D_USP14_chr18_166819_+_DDB2_chr11_47259387_length(transcript)=914nt_BP=286nt GCCGCCGCCGCAGCTGCTCCTGGTCCCCGTCCCTTTGCCGCCCTCGTCAGGCCCAGCTCTCCTGCGCCGCCGCCTCCCGCCGCGCCCCGC CATGCCGCTCTACTCCGTTACTGTAAAATGGGGAAAGGAGAAATTTGAAGGTGTAGAATTGAATACAGATGAACCTCCAATGGTATTCAA GGCTCAGCTGTTTGCGTTGACTGGAGTCCAGCCTGCCAGACAGAAAGTTATGGTGAAAGGAGGAACGCTAAAGGATGATGATTGGGGAAA CATCAAAATAAAAAATGCAGCCTGGCATCCTCGCTACAACCTCATTGTTGTGGGCCGATACCCAGATCCTAATTTCAAAAGTTGTACCCC TTATGAATTGAGGACGATCGACGTGTTCGATGGAAACTCAGGGAAGATGATGTGTCAGCTCTATGACCCAGAATCTTCTGGCATCAGTTC GCTTAATGAATTCAATCCCATGGGGGACACGCTGGCCTCTGCAATGGGTTACCACATTCTCATCTGGAGCCAGGAGGAAGCCAGGACACG GAAGTGAGAGACACTAAAGAAGGTGTGGGCCAGACAAGGCCTTGGAGCCCACACATGGGATCAAGTCCTGCAAGCAGAGGTGGCGATTTG TTAAAGGGCCAAAAGTATCCAAGGTTAGGGTTGGAGCAGGGGTGCTGGGACCTGGGGCACTGTGGGACTGGGACACTTTTATGTTAATGC TCTGGACTTGCCTCCAGAGACTGCTCCAGAGTTGGTGACACAGCTGTCCCAAGGGCCCCTCTGTATCTAGCCTGGAACCAAGGTTATCTT GGAACTAAATGACTTTTCTCCTCTCAGTGGGTGGTAGCAGAGGGATCAAGCAGTTATTTGATTTGTGCTCACTTTTGATATGGCCAATAA >In-frame_ENST00000261601_ENST00000378600_TCGA-VR-AA4D_USP14_chr18_166819_+_DDB2_chr11_47259387_length(amino acids)=177AA_start in transcript=13_stop in transcript=546 MLLVPVPLPPSSGPALLRRRLPPRPAMPLYSVTVKWGKEKFEGVELNTDEPPMVFKAQLFALTGVQPARQKVMVKGGTLKDDDWGNIKIK -------------------------------------------------------------- >In-frame_ENST00000261601_ENST00000378603_TCGA-VR-AA4D_USP14_chr18_166819_+_DDB2_chr11_47259387_length(transcript)=914nt_BP=286nt GCCGCCGCCGCAGCTGCTCCTGGTCCCCGTCCCTTTGCCGCCCTCGTCAGGCCCAGCTCTCCTGCGCCGCCGCCTCCCGCCGCGCCCCGC CATGCCGCTCTACTCCGTTACTGTAAAATGGGGAAAGGAGAAATTTGAAGGTGTAGAATTGAATACAGATGAACCTCCAATGGTATTCAA GGCTCAGCTGTTTGCGTTGACTGGAGTCCAGCCTGCCAGACAGAAAGTTATGGTGAAAGGAGGAACGCTAAAGGATGATGATTGGGGAAA CATCAAAATAAAAAATGCAGCCTGGCATCCTCGCTACAACCTCATTGTTGTGGGCCGATACCCAGATCCTAATTTCAAAAGTTGTACCCC TTATGAATTGAGGACGATCGACGTGTTCGATGGAAACTCAGGGAAGATGATGTGTCAGCTCTATGACCCAGAATCTTCTGGCATCAGTTC GCTTAATGAATTCAATCCCATGGGGGACACGCTGGCCTCTGCAATGGGTTACCACATTCTCATCTGGAGCCAGGAGGAAGCCAGGACACG GAAGTGAGAGACACTAAAGAAGGTGTGGGCCAGACAAGGCCTTGGAGCCCACACATGGGATCAAGTCCTGCAAGCAGAGGTGGCGATTTG TTAAAGGGCCAAAAGTATCCAAGGTTAGGGTTGGAGCAGGGGTGCTGGGACCTGGGGCACTGTGGGACTGGGACACTTTTATGTTAATGC TCTGGACTTGCCTCCAGAGACTGCTCCAGAGTTGGTGACACAGCTGTCCCAAGGGCCCCTCTGTATCTAGCCTGGAACCAAGGTTATCTT GGAACTAAATGACTTTTCTCCTCTCAGTGGGTGGTAGCAGAGGGATCAAGCAGTTATTTGATTTGTGCTCACTTTTGATATGGCCAATAA >In-frame_ENST00000261601_ENST00000378603_TCGA-VR-AA4D_USP14_chr18_166819_+_DDB2_chr11_47259387_length(amino acids)=177AA_start in transcript=13_stop in transcript=546 MLLVPVPLPPSSGPALLRRRLPPRPAMPLYSVTVKWGKEKFEGVELNTDEPPMVFKAQLFALTGVQPARQKVMVKGGTLKDDDWGNIKIK -------------------------------------------------------------- >In-frame_ENST00000261601_ENST00000256996_TCGA-VR-AA4D_USP14_chr18_166819_+_DDB2_chr11_47259387_length(transcript)=914nt_BP=286nt GCCGCCGCCGCAGCTGCTCCTGGTCCCCGTCCCTTTGCCGCCCTCGTCAGGCCCAGCTCTCCTGCGCCGCCGCCTCCCGCCGCGCCCCGC CATGCCGCTCTACTCCGTTACTGTAAAATGGGGAAAGGAGAAATTTGAAGGTGTAGAATTGAATACAGATGAACCTCCAATGGTATTCAA GGCTCAGCTGTTTGCGTTGACTGGAGTCCAGCCTGCCAGACAGAAAGTTATGGTGAAAGGAGGAACGCTAAAGGATGATGATTGGGGAAA CATCAAAATAAAAAATGCAGCCTGGCATCCTCGCTACAACCTCATTGTTGTGGGCCGATACCCAGATCCTAATTTCAAAAGTTGTACCCC TTATGAATTGAGGACGATCGACGTGTTCGATGGAAACTCAGGGAAGATGATGTGTCAGCTCTATGACCCAGAATCTTCTGGCATCAGTTC GCTTAATGAATTCAATCCCATGGGGGACACGCTGGCCTCTGCAATGGGTTACCACATTCTCATCTGGAGCCAGGAGGAAGCCAGGACACG GAAGTGAGAGACACTAAAGAAGGTGTGGGCCAGACAAGGCCTTGGAGCCCACACATGGGATCAAGTCCTGCAAGCAGAGGTGGCGATTTG TTAAAGGGCCAAAAGTATCCAAGGTTAGGGTTGGAGCAGGGGTGCTGGGACCTGGGGCACTGTGGGACTGGGACACTTTTATGTTAATGC TCTGGACTTGCCTCCAGAGACTGCTCCAGAGTTGGTGACACAGCTGTCCCAAGGGCCCCTCTGTATCTAGCCTGGAACCAAGGTTATCTT GGAACTAAATGACTTTTCTCCTCTCAGTGGGTGGTAGCAGAGGGATCAAGCAGTTATTTGATTTGTGCTCACTTTTGATATGGCCAATAA >In-frame_ENST00000261601_ENST00000256996_TCGA-VR-AA4D_USP14_chr18_166819_+_DDB2_chr11_47259387_length(amino acids)=177AA_start in transcript=13_stop in transcript=546 MLLVPVPLPPSSGPALLRRRLPPRPAMPLYSVTVKWGKEKFEGVELNTDEPPMVFKAQLFALTGVQPARQKVMVKGGTLKDDDWGNIKIK -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for USP14-DDB2 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for USP14-DDB2 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for USP14-DDB2 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | DDB2 | C1848411 | XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E | 9 | CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT |